Magnesium Orotate and the Microbiome-Gut-Brain Axis Modulation: New Approaches in Psychological Comorbidities of Gastrointestinal Functional Disorders.
Study Goal
The researchers aimed to review the efficiency of magnesium orotate therapy and probiotic supplementation in patients with both digestive and psychiatric symptoms, focusing on gut-brain axis modulation.
Results Summary
The abstract suggests magnesium orotate may be effective as an adjuvant in gastroenterological and psychiatric disorders, particularly in cases with overlapping symptoms, but does not provide specific outcome data.
Population
Pediatric and adult patients with gastroenterological and psychiatric symptoms.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
magnesium orotate | neutral | pediatric and adult gastroenterological disorders associated with dysbiosis | - | - | possible adjuvant | #1 |
magnesium orotate | neutral | psychiatric disorders' treatment, such as major depression and anxiety | - | - | adding | #2 |
magnesium orotate therapy | neutral | cases with both gastroenterological and psychiatric symptoms | - | - | efficiency | #3 |
magnesium orotate treatment and probiotic supplementation | neutral | patients with both digestive and psychiatric symptoms | patients with both digestive and psychiatric symptoms | - | targeting | #4 |
magnesium orotate and probiotics | neutral | both the pediatric and adult communities | pediatric and adult communities | - | compare the efficiency | #5 |
magnesium orotate and probiotics | neutral | clinical evolution of these patients | these patients | - | focusing on the possibility of gut-brain axis modulation | #6 |
Magnesium orotate has been cited in the medical literature for the past three years as a possible adjuvant in some pediatric and adult gastroenterological disorders associated with dysbiosis. Studies also focus on the possibility of adding magnesium orotate in psychiatric disorders' treatment, such as major depression and anxiety. The most relevant element in these studies is the efficiency of magnesium orotate therapy in cases with both gastroenterological and psychiatric symptoms. This article proposes a literature review, focused on the studies published in the last three years, targeting magnesium orotate treatment and probiotic supplementation in patients with both digestive and psychiatric symptoms. Moreover, this review will compare the efficiency of magnesium orotate and probiotics within both the pediatric and adult communities, focusing on the possibility of gut-brain axis modulation and its involvement in the clinical evolution of these patients.